Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: We studied the independent and joint effects of the genes encoding alpha‐synuclein (SNCA) and microtubule‐associated protein tau (MAPT) in Parkinson disease (PD) as part of a large meta‐analysis of individual data from case–control studies participating in the Genetic Epidemiology of Parkinson's Disease (GEO‐PD) consortium. Methods: Participants of Caucasian ancestry were genotyped for a total of 4 SNCA (rs2583988, rs181489, rs356219, rs11931074) and 2 MAPT (rs1052553, rs242557) single nucleotide polymorphism (SNPs). Individual and joint effects of SNCA and MAPT SNPs were investigated using fixed‐ and random‐effects logistic regression models. Interactions were studied on both a multiplicative and an additive scale, and using a case–control and case‐only approach. Results: Fifteen GEO‐PD sites contributed a total of 5,302 cases and 4,161 controls. All 4 SNCA SNPs and the MAPT H1‐haplotype–defining SNP (rs1052553) displayed a highly significant marginal association with PD at the significance level adjusted for multiple comparisons. For SNCA, the strongest associations were observed for SNPs located at the 3′ end of the gene. There was no evidence of statistical interaction between any of the 4 SNCA SNPs and rs1052553 or rs242557, neither on the multiplicative nor on the additive scale. Interpretation: This study confirms the association between PD and both SNCA SNPs and the H1 MAPT haplotype. It shows, based on a variety of approaches, that the joint action of variants in these 2 loci is consistent with independent effects of the genes without additional interacting effects. ANN NEUROL 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detecting gene–gene interactions that underlie human diseases
Cordell, H. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2579 · Cited by 1,350
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879
ROTHMAN, K. J., GREENLAND, S., & WALKER, A. M. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113015 · Cited by 859 · cited 1×
“The relevant scale to test for statistical interaction has been a subject of intense debate in the epidemiological community, and there is no consensus about the most appropriate method.(41,42) The multiplicative scale has been most often used for dichotomous outcomes mainly due to an easier implementation using logis…”
MethodAssociation of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781 · cited 1×
“Mutations in the MAPT gene cause frontotemporal dementia with parkinsonism, and there is consistent evidence that PSP is associated with the MAPT H1 haplotype.(23,39) There is increasing evidence from candidate gene studies(10) and GWASs that the H1 MAPT haplotype is also associated with PD among Caucasians.”
BackgroundSelf-citationA brief history of research synthesis
Chalmers, I., Hedges, L. V., & Cooper, H. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702025001003 · Cited by 552
SYNERGY AND ANTAGONISM IN CAUSE-EFFECT RELATIONSHIPS1
ROTHMAN, K. J. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121626 · Cited by 250
Rademakers, R., Melquist, S., Cruts, M., Theuns, J., Del-Favero, J., Poorkaj, P., Baker, M., Sleegers, K., Crook, R., De Pooter, T., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi361 · Cited by 164 · cited 3×
“The rs1052553 A-allele defines the MAPT H1 haplotype(10); rs242557 highlights the MAPT H1c subhaplotype associated with PSP.(23) Genotyping was performed on a Sequenom MassArray iPLEX platform (San Diego, CA); primer sequences are available upon request.”
BackgroundMethodSufficient cause interactions and statistical interactions
VanderWeele, T. J. (2009) · Epidemiology · doi:10.1097/ede.0b013e31818f69e7 · Cited by 163 · cited 1×
“It has been argued, however, that biologic interactions are more likely to lead to departure from additive effects of 2 variables.(25,26,43) As we were concerned that we may have failed to detect an interaction on the additive scale, we investigated additive interactions and found that the pattern of association was n…”
BackgroundWhen One Depends on the Other: Reporting of Interaction in Case-Control and Cohort Studies
Knol, M. J., Egger, M., Scott, P., Geerlings, M. I., & Vandenbroucke, J. P. (2009) · Epidemiology · doi:10.1097/ede.0b013e31818f6651 · Cited by 113 · cited 2×
“It has been argued, however, that biologic interactions are more likely to lead to departure from additive effects of 2 variables.(25,26,43) As we were concerned that we may have failed to detect an interaction on the additive scale, we investigated additive interactions and found that the pattern of association was n…”
BackgroundMethod
Cited by
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationNeuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
PART is part of Alzheimer disease
Duyckaerts, C., Braak, H., Brion, J.-P., Buée, L., Del Tredici, K., Goedert, M., Halliday, G., Neumann, M., Spillantini, M. G., Tolnay, M., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1390-7 · Cited by 316
DNAJC13 mutations in Parkinson disease
Vilariño-Güell, C., Rajput, A., Milnerwood, A. J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Encarnacion, M., Munsie, L. N., Tapia, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt570 · Cited by 313
Self-citationAlpha-synuclein and tau: teammates in neurodegeneration?
Moussaud, S., Jones, D. R., Moussaud-Lamodière, E. L., Delenclos, M., Ross, O. A., & McLean, P. J. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-43 · Cited by 287
Self-citation
Metadata
- Authors
- Elbaz, A., Ross, O. A., Ioannidis, J. P. A., Soto‐Ortolaza, A. I., Moisan, F., Aasly, J., Annesi, G., Bozi, M., Brighina, L., Chartier‐Harlin, M., Destée, A., Ferrarese, C., Ferraris, A., Gibson, J. M., Gispert, S., Hadjigeorgiou, G. M., Jasinska‐Myga, B., Klein, C., Krüger, R., Lambert, J., Lohmann, K., van de Loo, S., Loriot, M., Lynch, T., Mellick, G. D., Mutez, E., Nilsson, C., Opala, G., Puschmann, A., Quattrone, A., Sharma, M., Silburn, P. A., Stefanis, L., Uitti, R. J., Valente, E. M., Vilariño‐Güell, C., Wirdefeldt, K., Wszolek, Z. K., Xiromerisiou, G., Maraganore, D. M., Farrer, M. J., & on behalf of the Genetic Epidemiology of Parkinson's Disease (GEO‐PD) consortium
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-03-09
- Volume
- 69
- Issue
- 5
- Pages
- 778-792
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2033274736
- Cited by
- 90
- References
- 9
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.